D
Stoke Therapeutics, Inc. STOK
$19.56 -$0.12-0.61% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025
Revenue -91.29% 601.20%
Total Other Revenue -- --
Total Revenue -91.29% 601.20%
Cost of Revenue -- --
Gross Profit -91.29% 601.20%
SG&A Expenses 4.16% 14.08%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -13.13% 30.50%
Operating Income -124.54% 914.77%
Income Before Tax -120.57% 1,189.08%
Income Tax Expenses -- --
Earnings from Continuing Operations -120.80% 1,176.88%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -120.80% 1,176.88%
EBIT -124.54% 914.77%
EBITDA -124.04% 951.05%
EPS Basic -120.63% 1,161.37%
Normalized Basic EPS -120.40% 1,173.19%
EPS Diluted -121.18% 1,133.73%
Normalized Diluted EPS -120.94% 1,145.43%
Average Basic Shares Outstanding 0.85% 1.46%
Average Diluted Shares Outstanding -1.76% 4.15%
Dividend Per Share -- --
Payout Ratio -- --